Answer
Onkotrone (mitoxantrone hydrochloride) is indicated for metastatic breast cancer, non-Hodgkin's lymphoma, adult acute myeloid leukaemia, combination remission-induction treatment of blast crisis in chronic myeloid leukaemia, and, with corticosteroids, palliation related to advanced castrate-resistant prostate cancer.
Sources for this answer
- Onkotrone Injection 2 mg/ml concentrate for solution for infusionBaxter Healthcare Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 3Document updated
Sources checked